-
EP3393502
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3393502
| EP3393502 - COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.03.2023 Database last updated on 13.11.2024 | |
| Former | Examination is in progress Status updated on 07.08.2020 | ||
| Former | Request for examination was made Status updated on 28.09.2018 | ||
| Former | The international publication has been made Status updated on 23.06.2017 | Most recent event Tooltip | 17.03.2023 | Application deemed to be withdrawn | published on 19.04.2023 [2023/16] | Applicant(s) | For all designated states Codexis, Inc. 200 Penobscot Drive Redwood City, CA 94063 / US | [2020/32] |
| Former [2018/44] | For all designated states Nepetx, LLC 1234 Airport Road, Suite 105 Destin, FL 32541 / US | Inventor(s) | 01 /
SCHRIEMER, David C. c/o Nepetx LLC 1234 Airport Road Suite 105 Destin Florida 32541 / US | 02 /
REY, Martial c/o Neptex LLC 1234 Airport Road Suite 105 Destin Florida 32541 / US | [2018/44] | Representative(s) | Gibson, Mark Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2018/44] | Gibson, Mark Sagittarius IP Three Globeside Fieldhouse Lane Marlow, Buckinghamshire SL7 1HZ / GB | Application number, filing date | 16876878.6 | 16.12.2016 | [2018/44] | WO2016US67392 | Priority number, date | US201562268445P | 16.12.2015 Original published format: US 201562268445 P | [2018/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2017106798 | Date: | 22.06.2017 | Language: | EN | [2017/25] | Type: | A2 Application without search report | No.: | EP3393502 | Date: | 31.10.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.06.2017 takes the place of the publication of the European patent application. | [2018/44] | Search report(s) | International search report - published on: | KR | 27.07.2017 | (Supplementary) European search report - dispatched on: | EP | 15.05.2019 | Classification | IPC: | A61K38/43, A61K38/46, A61K9/00 | [2018/44] | CPC: |
A61K38/488 (EP,US);
A61K38/48 (EP,US);
A61K45/06 (US);
A61K9/0053 (US);
A61P1/14 (US);
A61P17/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P37/06 (EP);
C12N9/63 (US);
C12Y304/23012 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/44] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON GLUTENUNVERTRÄGLICHKEIT UND DARAUS ENTSTEHENDEN ERKRANKUNGEN | [2018/44] | English: | COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM | [2018/44] | French: | COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE L'INTOLÉRANCE AU GLUTEN ET DES TROUBLES QUI EN DÉCOULENT | [2018/44] | Entry into regional phase | 13.07.2018 | National basic fee paid | 13.07.2018 | Search fee paid | 13.07.2018 | Designation fee(s) paid | 13.07.2018 | Examination fee paid | Examination procedure | 13.07.2018 | Examination requested [2018/44] | 13.07.2018 | Date on which the examining division has become responsible | 16.04.2020 | Amendment by applicant (claims and/or description) | 11.08.2020 | Despatch of a communication from the examining division (Time limit: M04) | 03.12.2020 | Reply to a communication from the examining division | 15.03.2021 | Despatch of a communication from the examining division (Time limit: M02) | 21.05.2021 | Reply to a communication from the examining division | 24.09.2021 | Despatch of a communication from the examining division (Time limit: M04) | 02.02.2022 | Reply to a communication from the examining division | 11.05.2022 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2022 | Application deemed to be withdrawn, date of legal effect [2023/16] | 13.12.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/16] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 16.04.2020 | Request for further processing filed | 16.04.2020 | Full payment received (date of receipt of payment) Request granted | 28.04.2020 | Decision despatched | Fees paid | Renewal fee | 28.03.2019 | Renewal fee patent year 03 | 14.05.2020 | Renewal fee patent year 04 | 28.12.2020 | Renewal fee patent year 05 | 27.12.2021 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.12.2018 | 03 M06 Fee paid on 28.03.2019 | 31.12.2019 | 04 M06 Fee paid on 14.05.2020 | 31.12.2022 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2014138927 (SCHRIEMER DAVID [CA], et al) [X] 1-10 * the whole document *; | [XP]WO2015192211 (SCHRIEMER DAVID [CA], et al) [XP] 1-15 * the whole document *; | [T] - CHRISTOPH U. SCHRÄDER ET AL, "Neprosin, a Selective Prolyl Endoprotease for Bottom-up Proteomics and Histone Mapping", MOLECULAR & CELLULAR PROTEOMICS, US, (20170601), vol. 16, no. 6, doi:10.1074/mcp.M116.066803, ISSN 1535-9476, pages 1162 - 1171, XP055586181 [T] 1-15 DOI: http://dx.doi.org/10.1074/mcp.M116.066803 | [IP] - LINDA LEE ET AL, "Carnivorous Nutrition in Pitcher Plants ( Nepenthes spp.) via an Unusual Complement of Endogenous Enzymes", JOURNAL OF PROTEOME RESEARCH, (20160902), vol. 15, no. 9, doi:10.1021/acs.jproteome.6b00224, ISSN 1535-3893, pages 3108 - 3117, XP055586282 [IP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1021/acs.jproteome.6b00224 | International search | [A]US2012156253 (SHAN LU [US], et al) [A] 19-21 * See the whole document. *; | [A]US2014140980 (SCHRIEMER DAVID [CA]) [A] 19-21 * See paragraph [0051]; claims 6, 8. *; | [A]US2015352195 (BERNER BRET [US], et al) [A] 19-21 * See the whole document. *; | [A] - GOTTLIEB et al., "Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials", Gastroenterology Report, (20150226), vol. 3, no. 2, pages 91 - 102, XP055400635 [A] 19-21 * See the whole document. * DOI: http://dx.doi.org/10.1093/gastro/gov006 | [A] - FREEMAN, "Pearls and pitfalls in the diagnosis of adult celiac disease", Canadian Journal of Gastroenterology and Hepatology, (20080000), vol. 22, no. 3, pages 273 - 280, XP055244694 [A] 19-21 * See the whole document. * | [PX] - REY et al., "Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease", Scientific Reports, (20160802), vol. 6, no. 30980, pages 1 - 13, XP055313418 [PX] 19-21 * See abstract; pages 2, 8; Figure 2. * DOI: http://dx.doi.org/10.1038/srep30980 |